Status
Acquired by Biotie Therapies on January 11, 2011
Funding Received
$91.5 Million in 3 Rounds from 9 Investors
Headquarters:
Basel
Description:
Synosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology.
Categories:
Biotechnology
Website:
http://www.synosia.com

Company Details

Update

Synosia Therapeutics develops and intends to commercialise products for unmet medical needs in psychiatry and neurology. The privately-owned company has in its pipeline six clinical-stage compounds acquired through partnerships with Novartis, Roche and Syngenta. Two of the compounds are marketed drugs being tested in new indications to extend their reach into neurological and psychiatric diseases with high unmet medical need, including anxiety and Parkinson's disease.

Current Team (2)

Update

Past Team (1)

Update

Board Members and Advisors (2)

Update

Investors (9)

Update

Offices/Locations (1)

Update
  • Headquarters

    Aeschenvorstadt 36

    CH-4051

    Basel,

    CHE